Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 4/2017

01-04-2017 | Letter to the Editor

Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial

Author: Manuel Martínez-Lavín

Published in: Clinical Rheumatology | Issue 4/2017

Login to get access

Excerpt

To the Editor: …
Literature
1.
Martínez-Lavín M, Martínez-Martínez LA, Reyes-Loyola P (2015) HPV vaccination syndrome. A questionnaire-based study. Clin Rheumatol 34:1981–1983CrossRefPubMed
2.
Joura EA, Giuliano AR, Iversen OE et al (2015) A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 372:711–723CrossRefPubMed
Metadata
Title
Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial
Author
Manuel Martínez-Lavín
Publication date
01-04-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 4/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3575-z

Other articles of this Issue 4/2017

Clinical Rheumatology 4/2017 Go to the issue

Original Article

Functional limitation and associated factors in outpatients with ankylosing spondylitis in Southwest China

Brief Report

Association of human leukocyte A, B, and DR antigens in Colombian patients with diagnosis of spondyloarthritis

Original Article

Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab—a substudy of the optimized treatment algorithm in early RA (OPERA) trial

Original Article

Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry

Brief Report

Ultrasound resistive index, power Doppler, and clinical parameters in established rheumatoid arthritis

Brief Report

Maintenance of efficacy and safety with subcutaneous golimumab in rheumatoid arthritis patients with low disease activity who previously received TNF inhibitors
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits